Bio-Rad Laboratories (BIO) Gross Margin Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -285.00 |
| Dec 31, 2025 | -846.00 |
| Sep 30, 2025 | -416.00 |
| Jun 30, 2025 | -158.00 |
| Mar 31, 2025 | -326.00 |
| Dec 31, 2024 | -167.00 |
| Sep 30, 2024 | 2.00 |
| Jun 30, 2024 | 186.00 |
| Mar 31, 2024 | -293.00 |
| Dec 31, 2023 | -14.00 |
| Sep 30, 2023 | 51.00 |
| Jun 30, 2023 | 84.00 |
| Mar 31, 2023 | -125.00 |
| Dec 31, 2022 | -119.00 |
| Sep 30, 2022 | -125.00 |
| Jun 30, 2022 | 298.00 |
| Mar 31, 2022 | 350.00 |
| Dec 31, 2021 | -44.00 |
| Sep 30, 2021 | 349.00 |
| Jun 30, 2021 | 181.00 |
| Mar 31, 2021 | -92.00 |
| Dec 31, 2020 | 419.00 |
| Sep 30, 2020 | 68.00 |
| Jun 30, 2020 | -67.00 |
| Mar 31, 2020 | -160.00 |
| Dec 31, 2019 | -15.00 |
| Sep 30, 2019 | 37.00 |
| Jun 30, 2019 | -161.00 |
| Mar 31, 2019 | 223.00 |
| Dec 31, 2018 | 36.00 |
| Sep 30, 2018 | -367.00 |
| Jun 30, 2018 | -474.00 |
| Mar 31, 2018 | 48.00 |
| Sep 30, 2017 | 108.00 |
| Jun 30, 2017 | -224.00 |
| Mar 31, 2017 | -330.00 |
| Dec 31, 2016 | -151.00 |
| Sep 30, 2016 | -240.00 |
| Jun 30, 2016 | -196.00 |
| Mar 31, 2016 | -120.00 |
| Dec 31, 2015 | -209.00 |
| Sep 30, 2015 | -42.00 |
| Jun 30, 2015 | -212.00 |
| Mar 31, 2015 | 52.00 |
| Dec 31, 2014 | -117.00 |
| Sep 30, 2014 | -211.00 |
| Jun 30, 2014 | -128.00 |